Ruth Garcia-Romero
Overview
Explore the profile of Ruth Garcia-Romero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Romero R, Cancho Candela R, Pena Segura J, Navas-Lopez V, Diaz Martin J
An Pediatr (Engl Ed)
. 2025 Mar;
:503803.
PMID: 40024833
Introduction: Cerebral palsy (CP) encompasses a group of motor disorders that can result in swallowing difficulties, affecting food intake and contributing to poor nutritional status. The goal of the study...
2.
Vicente-Santamaria S, Tabares-Gonzalez A, Gascon-Galindo C, Tutau-Gomez C, Alvarez-Beltran M, Munoz-Codoceo R, et al.
Eur J Gastroenterol Hepatol
. 2025 Feb;
PMID: 39976013
Background: Cystic fibrosis-related liver disease (CFRLD) is a health problem that can affect as many as 30-40% of cystic fibrosis patients by the age of 12 years. We studied the...
3.
Weintraub Y, Collen L, Hussey S, Mitrova K, Machta J, Kang B, et al.
Inflamm Bowel Dis
. 2025 Jan;
PMID: 39813158
Background And Aims: Patients with very early-onset inflammatory bowel disease (VEO-IBD), with an age of onset < 6 years, can present with severe manifestations and may require biologic therapy. Infliximab...
4.
Vicente-Santamaria S, Vicente-Santamaria S, Torres-Guerrero M, Torres-Guerrero M, Garcia-Gonzalez M, Garcia-Gonzalez M, et al.
Gastroenterol Hepatol
. 2024 Dec;
:502321.
PMID: 39675556
Background: Cystic fibrosis (CF) is an autosomal recessive, chronic, potentially lethal genetic disease. CF manifestations are due to mutations in the CF transmembrane receptor transporter (CFTR) gene which codes for...
5.
Garcia-Martinez de Bartolome R, Barrio-Torres J, Sebastian-Viana T, Vila-Miravet V, La Orden-Izquierdo E, Fernandez-Fernandez S, et al.
J Pediatr Gastroenterol Nutr
. 2024 Dec;
80(2):308-317.
PMID: 39663749
Objectives: To study the health-related quality of life (HRQoL) and its possible determinant factors in Spanish children with eosinophilic esophagitis (EoE) and their parents. Methods: Multicenter observational cross-sectional study. The...
6.
Quesada-Colloto P, Avello-Llano N, Garcia-Romero R, Garriga-Garcia M, Alvarez-Beltran M, Reyes-Dominguez A, et al.
Nutrients
. 2024 Nov;
16(22).
PMID: 39599636
Objectives/background: Vitamin D-binding protein (VDBP) and free vitamin D are new markers that are being studied as a possible markers of vitamin D status. The main aim of our study...
7.
Pujol-Muncunill G, Navas-Lopez V, Ledder O, Cohen S, Lekar M, Turner D, et al.
Eur J Pediatr
. 2024 May;
183(8):3253-3262.
PMID: 38700692
Ustekinumab is an effective therapy for adult Crohn's disease (CD), but data in paediatric CD patients are scarce. The aim of the study was to describe the real-life effectiveness and...
8.
German-Diaz M, Alcolea A, Cabello V, Blasco-Alonso J, Rodriguez A, Galera R, et al.
Eur J Pediatr
. 2024 Apr;
183(8):3173-3182.
PMID: 38664251
Teduglutide is a glucagon-like-peptide-2 analogue that reduces the need for parenteral support in patients with short bowel syndrome (SBS). Nevertheless, data about long-term therapy with teduglutide in children are still...
9.
Salvador-Martin S, Rubbini G, Vellosillo P, Zapata-Cobo P, Velasco M, Palomino L, et al.
Biomed Pharmacother
. 2024 Feb;
173:116299.
PMID: 38401525
Background/aims: Changes in gene expression profiles among individuals with inflammatory bowel diseases (IBDs) could potentially influence the responsiveness to anti-TNF treatment. The aim of this study was to identify genes...
10.
Zapata-Cobo P, Salvador-Matin S, Velasco M, Palomino L, Clemente S, Segarra O, et al.
Pharmacol Res
. 2023 Sep;
196:106938.
PMID: 37748560
No abstract available.